Is it possible to quantify the mortality of a delay in diagnosing cancer?
As you well know, we represent folks in delay-of-diagnosing-cancer claims. That is, a patient will have presented with signs and symptoms of cancer, but a
As you well know, we represent folks in delay-of-diagnosing-cancer claims. That is, a patient will have presented with signs and symptoms of cancer, but a
A recent news article in Reuters described a surprising reduction in colorectal screenings, biopsies, and surgeries due to the Covid-19 pandemic. It is unmistakable that
Sometimes it feels like anything that can go wrong does. That certainly felt the case for our unfortunate client who suffered a tragic string of errors during her treatment and in litigation.
A recent meta-analysis study has corroborated earlier studies showing that regular aspirin may reduce the risk of gastrointestinal cancers, including pancreatic, colorectal, and esophageal cancers.
Researchers in the U.S. and the U.K. have developed a new blood test to detect cancer. The test, which may revolutionize cancer diagnosis, can detect
While plastic surfaces at hospitals harbor untold numbers of pathogens, replacing some surfaces with copper will decrease likelihood of hospital acquired infections thanks to the natural antimicrobial properties of the element.
Causation can be a very difficult, and sometimes insurmountable, hurdle in bringing a successful claim alleging a delay in diagnosing a condition.
Fungus candida auris is causing a serious global health threat due to recent outbreaks and a difficulty in treating it.
A recent paper published found that 71% of reusable medical scopes tested at three major hospitals carried bacteria.
There has been no consensus among cardiologists about whether cardiac disease screening should be done and how effective it is in determining risk of heart disease.